Behavioral Voluntary and Social Bioassays Enabling Identification of Complex and Sex-Dependent Pain-(-Related) Phenotypes in Rats with Bone Cancer.
Daniel SegelckeJan LinnemannBruno PradierDaniel KronenbergRichard StangeS Helene RichterDennis GörlichNicola BaldiniGemma Di PompoWaldiceu Aparecido VerriSofia AvnetEsther M Pogatzki-ZahnPublished in: Cancers (2023)
Cancer-induced bone pain (CIBP) is a common and devastating symptom with limited treatment options in patients, significantly affecting their quality of life. The use of rodent models is the most common approach to uncovering the mechanisms underlying CIBP; however, the translation of results to the clinic may be hindered because the assessment of pain-related behavior is often based exclusively on reflexive-based methods, which are only partially indicative of relevant pain in patients. To improve the accuracy and strength of the preclinical, experimental model of CIBP in rodents, we used a battery of multimodal behavioral tests that were also aimed at identifying rodent-specific behavioral components by using a home-cage monitoring assay (HCM). Rats of all sexes received an injection with either heat-deactivated (sham-group) or potent mammary gland carcinoma Walker 256 cells into the tibia. By integrating multimodal datasets, we assessed pain-related behavioral trajectories of the CIBP-phenotype, including evoked and non-evoked based assays and HCM. Using principal component analysis (PCA), we discovered sex-specific differences in establishing the CIBP-phenotype, which occurred earlier (and differently) in males. Additionally, HCM phenotyping revealed the occurrence of sensory-affective states manifested by mechanical hypersensitivity in sham when housed with a tumor-bearing cagemate (CIBP) of the same sex. This multimodal battery allows for an in-depth characterization of the CIBP-phenotype under social aspects in rats. The detailed, sex-specific, and rat-specific social phenotyping of CIBP enabled by PCA provides the basis for mechanism-driven studies to ensure robustness and generalizability of results and provide information for targeted drug development in the future.
Keyphrases
- pain management
- chronic pain
- neuropathic pain
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- high throughput
- mental health
- chronic kidney disease
- hypertrophic cardiomyopathy
- papillary thyroid
- prognostic factors
- risk assessment
- drug induced
- heart failure
- induced apoptosis
- spinal cord
- oxidative stress
- squamous cell carcinoma
- patient reported outcomes
- depressive symptoms
- bone marrow
- patient reported
- cell cycle arrest
- mesenchymal stem cells
- body composition
- lymph node metastasis
- spinal cord injury
- soft tissue
- drug delivery
- postmenopausal women
- rna seq
- bipolar disorder
- ultrasound guided
- case control